Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Hong Kong Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20111
20131
20141
20171
20191
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Terminated3
Unknown status2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
The University of Hong Kong2
Bristol-Myers Squibb1
Gilead Sciences1
GlaxoSmithKline1
Janssen-Cilag Farmaceutica Ltda.1
Treadwell Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes14
Thrombocytopenia5
Leukemia, Myeloid, Acute4
Anemia2
Leukemia, Myelomonocytic, Chronic2
Anemia, Diamond-Blackfan1
Hematologic Neoplasms1
Myeloproliferative Disorders1
Purpura, Thrombocytopenic, Idiopathic1
Thalassemia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.